Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

QIAGEN Revenue 2010-2023 | QGEN

QIAGEN annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • QIAGEN revenue for the quarter ending June 30, 2023 was $0.495B, a 4.01% decline year-over-year.
  • QIAGEN revenue for the twelve months ending June 30, 2023 was $1.978B, a 12.52% decline year-over-year.
  • QIAGEN annual revenue for 2022 was $2.142B, a 4.89% decline from 2021.
  • QIAGEN annual revenue for 2021 was $2.252B, a 20.39% increase from 2020.
  • QIAGEN annual revenue for 2020 was $1.87B, a 22.53% increase from 2019.
  
QIAGEN Annual Revenue
(Millions of US $)
2022 $2,142
2021 $2,252
2020 $1,870
2019 $1,526
2018 $1,502
2017 $1,418
2016 $1,338
2015 $1,281
2014 $1,345
2013 $1,302
2012 $1,254
2011 $1,170
2010 $1,087
2009 $1,010
QIAGEN Quarterly Revenue
(Millions of US $)
2023-06-30 $495
2023-03-31 $485
2022-12-31 $498
2022-09-30 $500
2022-06-30 $516
2022-03-31 $628
2021-12-31 $582
2021-09-30 $535
2021-06-30 $567
2021-03-31 $567
2020-12-31 $571
2020-09-30 $484
2020-06-30 $443
2020-03-31 $372
2019-12-31 $413
2019-09-30 $383
2019-06-30 $382
2019-03-31 $349
2018-12-31 $403
2018-09-30 $378
2018-06-30 $377
2018-03-31 $344
2017-12-31 $397
2017-09-30 $364
2017-06-30 $349
2017-03-31 $308
2016-12-31 $367
2016-09-30 $339
2016-06-30 $334
2016-03-31 $298
2015-12-31 $349
2015-09-30 $315
2015-06-30 $319
2015-03-31 $298
2014-12-31 $360
2014-09-30 $336
2014-06-30 $331
2014-03-31 $317
2013-12-31 $361
2013-09-30 $322
2013-06-30 $315
2013-03-31 $304
2012-12-31 $347
2012-09-30 $304
2012-06-30 $307
2012-03-31 $296
2011-12-31 $334
2011-09-30 $289
2011-06-30 $282
2011-03-31 $264
2010-12-31 $286
2010-09-30 $274
2010-06-30 $263
2010-03-31 $264
2009-12-31 $289
2009-09-30 $260
2009-06-30 $240
2009-03-31 $221
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.988B $2.142B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.193B 15.06
Bristol Myers Squibb (BMY) United States $123.048B 7.74
Gilead Sciences (GILD) United States $93.464B 11.94
Vertex Pharmaceuticals (VRTX) United States $90.212B 26.58
Regeneron Pharmaceuticals (REGN) United States $89.544B 21.61
CSL (CSLLY) Australia $78.633B 0.00
GSK (GSK) United Kingdom $76.638B 10.40
Seagen (SGEN) United States $40.111B 0.00
Moderna (MRNA) United States $38.055B 36.90
Biogen (BIIB) United States $37.318B 15.87
Argenex SE (ARGX) Netherlands $29.610B 0.00
Horizon Therapeutics Public (HZNP) Ireland $26.474B 25.75
BioNTech SE (BNTX) Germany $25.217B 5.87
Genmab (GMAB) Denmark $23.833B 36.08
Alnylam Pharmaceuticals (ALNY) United States $21.444B 0.00
Illumina (ILMN) United States $20.965B 150.50
BeiGene (BGNE) Cayman Islands $18.457B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.279B 86.51
Incyte (INCY) United States $13.019B 31.75
Exact Sciences (EXAS) United States $12.077B 0.00
Bio-Techne Corp (TECH) United States $10.974B 39.13
Bio-Rad Laboratories (BIO.B) United States $10.868B 30.51
Sarepta Therapeutics (SRPT) United States $10.554B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $10.533B 0.00
Legend Biotech (LEGN) United States $10.426B 0.00
Repligen (RGEN) United States $8.952B 61.28
Roivant Sciences (ROIV) United Kingdom $7.972B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $6.961B 0.00
Exelixis (EXEL) United States $6.839B 42.12
Reata Pharmaceuticals (RETA) United States $6.574B 0.00
Karuna Therapeutics (KRTX) United States $6.254B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $5.888B 19.00
Ascendis Pharma (ASND) Denmark $5.433B 0.00
Halozyme Therapeutics (HALO) United States $5.220B 17.59
Intra-Cellular Therapies (ITCI) United States $5.158B 0.00
Apellis Pharmaceuticals (APLS) United States $5.153B 0.00
Vaxcyte (PCVX) United States $4.922B 0.00
Alkermes (ALKS) Ireland $4.834B 241.83
ACADIA Pharmaceuticals (ACAD) United States $3.857B 0.00
Insmed (INSM) United States $3.763B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.715B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.612B 0.00
Amicus Therapeutics (FOLD) United States $3.520B 0.00
Axsome Therapeutics (AXSM) United States $3.468B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.259B 0.00
Krystal Biotech (KRYS) United States $3.223B 0.00
Guardant Health (GH) United States $3.052B 0.00
Denali Therapeutics (DNLI) United States $3.044B 0.00
Blueprint Medicines (BPMC) United States $3.004B 0.00
Cytokinetics (CYTK) United States $2.971B 0.00
Intellia Therapeutics (NTLA) United States $2.866B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.758B 0.00
Prothena (PRTA) Ireland $2.730B 0.00
Immunovant (IMVT) United States $2.664B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.605B 0.00
Akero Therapeutics (AKRO) United States $2.553B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.547B 0.00
Nuvalent (NUVL) United States $2.486B 0.00
Fortrea Holdings (FTRE) United States $2.467B 0.00
Zai Lab (ZLAB) China $2.419B 0.00
Mirati Therapeutics (MRTX) United States $2.403B 0.00
Galapagos (GLPG) Belgium $2.324B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.256B 0.00
Certara (CERT) United States $2.250B 37.05
Zealand Pharma (ZLDPF) Denmark $2.222B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.177B 12.09
Ventyx Biosciences (VTYX) United States $2.027B 0.00
Beam Therapeutics (BEAM) United States $1.882B 0.00
Morphic Holding (MORF) United States $1.758B 0.00
Dynavax Technologies (DVAX) United States $1.757B 18.94
Bavarian Nordic (BVNRY) Denmark $1.731B 10.43
CureVac (CVAC) Germany $1.677B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.643B 0.00
Arcellx (ACLX) United States $1.642B 0.00
Vericel (VCEL) United States $1.620B 0.00
IDEAYA Biosciences (IDYA) United States $1.590B 0.00
NeoGenomics (NEO) United States $1.550B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.502B 0.00
SpringWorks Therapeutics (SWTX) United States $1.484B 0.00
Arcus Biosciences (RCUS) United States $1.469B 0.00
AbCellera Biologics (ABCL) Canada $1.447B 0.00
Myriad Genetics (MYGN) United States $1.360B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.326B 0.00
Structure Therapeutics (GPCR) United States $1.301B 0.00
Viking Therapeutics (VKTX) United States $1.288B 0.00
Vir Biotechnology (VIR) United States $1.255B 0.00
Arvinas (ARVN) United States $1.215B 0.00
Iovance Biotherapeutics (IOVA) United States $1.207B 0.00
89BIO (ETNB) United States $1.203B 0.00
Celldex Therapeutics (CLDX) United States $1.203B 0.00
Merus (MRUS) Netherlands $1.194B 0.00
ANI Pharmaceuticals (ANIP) United States $1.187B 19.00
Mirum Pharmaceuticals (MIRM) United States $1.177B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.168B 31.40
Twist Bioscience (TWST) United States $1.167B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.164B 0.00
Biohaven (BHVN) United States $1.157B 0.00
Revance Therapeutics (RVNC) United States $1.144B 0.00
Northwest Biotherapeutics (NWBO) United States $1.130B 0.00
Geron (GERN) United States $1.125B 0.00
Disc Medicine (IRON) United States $1.119B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.109B 0.00
MannKind (MNKD) United States $1.090B 0.00
Prime Medicine (PRME) United States $1.078B 0.00
Apogee Therapeutics (APGE) United States $1.058B 0.00
Tango Therapeutics (TNGX) United States $1.050B 0.00
Ligand Pharmaceuticals (LGND) United States $1.025B 22.72
Deciphera Pharmaceuticals (DCPH) United States $1.015B 0.00
Replimune (REPL) United States $0.990B 0.00
Protagonist Therapeutics (PTGX) United States $0.984B 0.00
ACELYRIN, INC (SLRN) United States $0.976B 0.00
Keros Therapeutics (KROS) United States $0.974B 0.00
Kymera Therapeutics (KYMR) United States $0.970B 0.00
Pharming Group (PHGUF) Netherlands $0.913B 0.00
Pliant Therapeutics (PLRX) United States $0.898B 0.00
Immatics (IMTX) Germany $0.898B 0.00
MiMedx (MDXG) United States $0.880B 0.00
Cytek Biosciences (CTKB) United States $0.870B 0.00
Belite Bio (BLTE) United States $0.858B 0.00
Cogent Biosciences (COGT) United States $0.856B 0.00
Inhibrx (INBX) United States $0.851B 0.00
Pharming Group (PHAR) Netherlands $0.847B 0.00
ADMA Biologics Inc (ADMA) United States $0.789B 0.00
PureTech Health (PRTC) United States $0.778B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.778B 0.00
Sana Biotechnology (SANA) United States $0.754B 0.00
ImmunityBio (IBRX) United States $0.753B 0.00
REGENXBIO (RGNX) United States $0.752B 0.00
POINT Biopharma Global (PNT) United States $0.742B 8.07
Adaptive Biotechnologies (ADPT) United States $0.733B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.725B 14.34
Ambrx Biopharma (AMAM) United States $0.702B 0.00
Viridian Therapeutics (VRDN) United States $0.679B 0.00
Novavax (NVAX) United States $0.673B 0.00
Genelux (GNLX) United States $0.663B 0.00
Kura Oncology (KURA) United States $0.658B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
Vera Therapeutics (VERA) United States $0.644B 0.00
Editas Medicine (EDIT) United States $0.641B 0.00
Cabaletta Bio (CABA) United States $0.630B 0.00
Pharma Mar (PHMMF) Spain $0.621B 0.00
Tyra Biosciences (TYRA) United States $0.612B 0.00
Allogene Therapeutics (ALLO) United States $0.612B 0.00
Avid Bioservices (CDMO) United States $0.606B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.604B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.604B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.593B 0.00
Rapt Therapeutics (RAPT) United States $0.592B 0.00
Travere Therapeutics (TVTX) United States $0.589B 0.00
Alector (ALEC) United States $0.577B 0.00
Anavex Life Sciences (AVXL) United States $0.565B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.553B 0.00
WAVE Life Sciences (WVE) Singapore $0.538B 0.00
Biomea Fusion (BMEA) United States $0.521B 0.00
Olema Pharmaceuticals (OLMA) United States $0.516B 0.00
Repare Therapeutics (RPTX) Canada $0.513B 0.00
HilleVax (HLVX) United States $0.511B 0.00
Entrada Therapeutics (TRDA) United States $0.479B 0.00
Avidity Biosciences (RNA) United States $0.478B 0.00
23andMe Holding (ME) United States $0.472B 0.00
Caribou Biosciences (CRBU) United States $0.449B 0.00
Agenus (AGEN) United States $0.448B 0.00
AnaptysBio (ANAB) United States $0.448B 0.00
Castle Biosciences (CSTL) United States $0.443B 0.00
Janux Therapeutics (JANX) United States $0.443B 0.00
Mineralys Therapeutics (MLYS) United States $0.439B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.438B 0.00
Zymeworks (ZYME) United States $0.434B 2.29
Nurix Therapeutics (NRIX) United States $0.427B 0.00
Oric Pharmaceuticals (ORIC) United States $0.426B 0.00
IGM Biosciences (IGMS) United States $0.425B 0.00
Coherus BioSciences (CHRS) United States $0.421B 0.00
Oculis Holding AG (OCS) Switzerland $0.417B 0.00
Icosavax (ICVX) United States $0.413B 0.00
Liquidia Technologies (LQDA) United States $0.413B 0.00
ITeos Therapeutics (ITOS) United States $0.409B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.406B 0.00
Cullinan Oncology (CGEM) United States $0.406B 0.00
Nautilus Biotechnology (NAUT) United States $0.399B 0.00
Edgewise Therapeutics (EWTX) United States $0.380B 0.00
Amarin (AMRN) Ireland $0.374B 0.00
Aerovate Therapeutics (AVTE) United States $0.369B 0.00
Urogen Pharma (URGN) United States $0.368B 0.00
Precigen (PGEN) United States $0.358B 0.00
Scholar Rock Holding (SRRK) United States $0.358B 0.00
Aura Biosciences (AURA) United States $0.353B 0.00
Erasca (ERAS) United States $0.340B 0.00
UniQure (QURE) Netherlands $0.338B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.336B 0.00
Seres Therapeutics (MCRB) United States $0.335B 0.00
Voyager Therapeutics (VYGR) United States $0.334B 3.35
Arcutis Biotherapeutics (ARQT) United States $0.332B 0.00
Apollomics (APLM) Taiwan $0.326B 0.00
Bluebird Bio (BLUE) United States $0.325B 0.00
Arbutus Biopharma (ABUS) United States $0.323B 0.00
MaxCyte (MXCT) United States $0.322B 0.00
Terns Pharmaceuticals (TERN) United States $0.316B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.307B 0.00
AN2 Therapeutics (ANTX) United States $0.300B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.298B 0.00
Humacyte (HUMA) United States $0.298B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.296B 0.00
MeiraGTx Holdings (MGTX) United States $0.295B 0.00
Nuvation Bio (NUVB) United States $0.291B 0.00
Inozyme Pharma (INZY) United States $0.284B 0.00
DBV Technologies S.A (DBVT) France $0.277B 0.00
Zura Bio (ZURA) United States $0.276B 0.00
Anika Therapeutics (ANIK) United States $0.268B 0.00
Atea Pharmaceuticals (AVIR) United States $0.267B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.262B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.259B 16.70
Fulcrum Therapeutics (FULC) United States $0.258B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.258B 0.00
Ovid Therapeutics (OVID) United States $0.257B 0.00
ScPharmaceuticals (SCPH) United States $0.252B 0.00
Compass Therapeutics (CMPX) United States $0.250B 0.00
AC Immune (ACIU) Switzerland $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.247B 0.00
Verastem (VSTM) United States $0.245B 0.00
Lifecore Biomedical (LFCR) United States $0.244B 0.00
Nuvectis Pharma (NVCT) United States $0.240B 0.00
Scilex Holding (SCLX) United States $0.236B 0.00
Kamada (KMDA) Israel $0.232B 17.83
Y-mAbs Therapeutics (YMAB) United States $0.228B 0.00
Renovaro Biosciences (RENB) United States $0.227B 0.00
Inventiva S.A (IVA) France $0.227B 0.00
Immuneering (IMRX) United States $0.224B 0.00
Gracell Biotechnologies (GRCL) China $0.221B 0.00
Celcuity (CELC) United States $0.220B 0.00
Akoya Biosciences (AKYA) United States $0.216B 0.00
Innate Pharma S.A (IPHA) France $0.215B 0.00
Fate Therapeutics (FATE) United States $0.208B 0.00
Sagimet Biosciences (SGMT) United States $0.208B 0.00
ALX Oncology Holdings (ALXO) United States $0.207B 0.00
Mesoblast (MESO) Australia $0.202B 0.00
CorMedix Inc (CRMD) United States $0.201B 0.00
Vigil Neuroscience (VIGL) United States $0.201B 0.00
Sutro Biopharma (STRO) United States $0.200B 0.00
TELA Bio (TELA) United States $0.198B 0.00
Astria Therapeutics (ATXS) United States $0.196B 0.00
Ikena Oncology (IKNA) United States $0.193B 0.00
Tenaya Therapeutics (TNYA) United States $0.192B 0.00
Allakos (ALLK) United States $0.189B 0.00
Praxis Precision Medicines (PRAX) United States $0.185B 0.00
Stoke Therapeutics (STOK) United States $0.185B 0.00
Rallybio (RLYB) United States $0.184B 0.00
Atara Biotherapeutics (ATRA) United States $0.181B 0.00
Gossamer Bio (GOSS) United States $0.180B 0.00
XOMA (XOMA) United States $0.180B 0.00
Invivyd (IVVD) United States $0.179B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.175B 0.00
Vaxxinity (VAXX) United States $0.175B 0.00
Prima BioMed (IMMP) Australia $0.174B 0.00
Omega Therapeutics (OMGA) United States $0.173B 0.00
X4 Pharmaceuticals (XFOR) United States $0.171B 0.00
Molecular Partners AG (MOLN) Switzerland $0.171B 0.00
Applied Therapeutics (APLT) United States $0.170B 0.00
Adverum Biotechnologies (ADVM) United States $0.170B 0.00
Emergent Biosolutions (EBS) United States $0.169B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.169B 0.00
GENFIT S.A (GNFT) France $0.167B 0.00
Poseida Therapeutics (PSTX) United States $0.165B 0.00
Selecta Biosciences (SELB) United States $0.163B 0.00
PDS Biotechnology (PDSB) United States $0.161B 0.00
LianBio (LIAN) United States $0.161B 0.00
2seventy Bio (TSVT) United States $0.159B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.158B 0.00
Oncolytics Biotech (ONCY) Canada $0.156B 0.00
Mersana Therapeutics (MRSN) United States $0.153B 0.00
Seer (SEER) United States $0.146B 0.00
Vor Biopharma (VOR) $0.146B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.143B 0.00
InflaRx (IFRX) Germany $0.139B 0.00
Rani Therapeutics Holdings (RANI) United States $0.138B 0.00
Ocean Biomedical (OCEA) United States $0.138B 0.00
Graphite Bio (GRPH) United States $0.138B 0.00
Puma Biotechnology (PBYI) United States $0.137B 0.00
Sangamo Therapeutics (SGMO) United States $0.137B 0.00
Absci (ABSI) United States $0.136B 0.00
Trevi Therapeutics (TRVI) United States $0.135B 0.00
Adocia (ADOCY) France $0.135B 0.00
Design Therapeutics (DSGN) United States $0.134B 0.00
XBiotech (XBIT) United States $0.133B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.129B 0.00
Annexon (ANNX) United States $0.128B 0.00
TScan Therapeutics (TCRX) United States $0.127B 0.00
INmune Bio (INMB) United States $0.124B 0.00
Decibel Therapeutics (DBTX) United States $0.123B 0.00
Aadi Bioscience (AADI) United States $0.122B 0.00
Theseus Pharmaceuticals (THRX) United States $0.122B 0.00
PepGen (PEPG) United States $0.122B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.119B 0.00
Gritstone Bio (GRTS) United States $0.116B 0.00
Greenwich LifeSciences (GLSI) United States $0.113B 0.00
Codexis (CDXS) United States $0.109B 0.00
DiaMedica Therapeutics (DMAC) United States $0.106B 0.00
Genenta Science S.p.A (GNTA) Italy $0.106B 0.00
Inovio Pharmaceuticals (INO) United States $0.106B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
Bionano Genomics (BNGO) United States $0.103B 0.00
Cue Biopharma (CUE) United States $0.103B 0.00
ChromaDex (CDXC) United States $0.103B 0.00
Ocugen (OCGN) United States $0.103B 0.00
MediciNova (MNOV) United States $0.103B 0.00
Kodiak Sciences (KOD) United States $0.102B 0.00
C4 Therapeutics (CCCC) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.100B 0.00
Opthea (OPT) Australia $0.099B 0.00
Graf Acquisition IV (GFOR) United States $0.099B 0.00
I-Mab (IMAB) China $0.099B 0.00
PhenomeX (CELL) United States $0.098B 0.00
Spruce Biosciences (SPRB) United States $0.097B 0.00
IO Biotech (IOBT) Denmark $0.097B 0.00
Cellectis S.A (CLLS) France $0.096B 0.00
Abeona Therapeutics (ABEO) United States $0.094B 0.00
Cidara Therapeutics (CDTX) United States $0.092B 0.00
ATyr Pharma (LIFE) United States $0.092B 0.00
Cara Therapeutics (CARA) United States $0.090B 0.00
Gamida Cell (GMDA) United States $0.090B 0.00
Annovis Bio (ANVS) United States $0.089B 0.00
Immunome (IMNM) United States $0.088B 0.00
NGM Biopharmaceuticals (NGM) United States $0.087B 0.00
BRIACELL THERAP (BCTX) Canada $0.087B 0.00
Jasper Therapeutics (JSPR) United States $0.086B 0.00
BioAtla (BCAB) United States $0.086B 0.00
CytomX Therapeutics (CTMX) United States $0.085B 0.00
BioXcel Therapeutics (BTAI) United States $0.085B 0.00
Compugen (CGEN) Israel $0.085B 0.00
Data Knights Acquisition (DKDCA) United Kingdom $0.085B 0.00
Beyond Air (XAIR) United States $0.084B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.084B 0.00
Kezar Life Sciences (KZR) United States $0.083B 0.00
Syros Pharmaceuticals (SYRS) United States $0.082B 0.00
Turnstone Biologics (TSBX) United States $0.082B 0.00
Genetron Holdings (GTH) China $0.082B 0.00
Ocuphire Pharma (OCUP) United States $0.081B 4.61
Nkarta (NKTX) United States $0.079B 0.00
Werewolf Therapeutics (HOWL) United States $0.079B 0.00
Kronos Bio (KRON) United States $0.076B 0.00
Athira Pharma (ATHA) United States $0.075B 0.00
Evelo Biosciences (EVLO) United States $0.075B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.075B 0.00
HCW Biologics (HCWB) United States $0.074B 0.00
Cardiff Oncology (CRDF) United States $0.072B 0.00
Affimed (AFMD) Germany $0.069B 0.00
Enzo Biochem (ENZ) United States $0.068B 0.00
AVROBIO (AVRO) United States $0.068B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.067B 0.00
Kinnate Biopharma (KNTE) United States $0.066B 0.00
Sorrento Therapeutics (SRNEQ) United States $0.066B 0.00
Elicio Therapeutics (ELTX) United States $0.066B 0.00
Prenetics Global (PRE) Cayman Islands $0.065B 1.54
Shattuck Labs (STTK) United States $0.064B 0.00
Spero Therapeutics (SPRO) United States $0.064B 0.00
G1 Therapeutics (GTHX) United States $0.064B 0.00
Vaccitech (VACC) United Kingdom $0.063B 0.00
Adicet Bio (ACET) United States $0.063B 0.00
Xilio Therapeutics (XLO) United States $0.061B 0.00
Eyenovia (EYEN) United States $0.061B 0.00
Immunic (IMUX) United States $0.061B 0.00
Clene (CLNN) United States $0.059B 0.00
Dyadic (DYAI) United States $0.058B 0.00
Alpha Teknova (TKNO) United States $0.057B 0.00
Adagene (ADAG) China $0.057B 0.00
Immix Biopharma (IMMX) United States $0.056B 0.00
Solid Biosciences (SLDB) United States $0.055B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.055B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
Instil Bio (TIL) United States $0.054B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
Curis (CRIS) United States $0.053B 0.00
Rezolute (RZLT) United States $0.052B 0.00
Theratechnologies (THTX) Canada $0.052B 0.00
Dianthus Therapeutics (DNTH) United States $0.051B 0.00
OKYO Pharma (OKYO) $0.051B 0.00
HOOKIPA Pharma (HOOK) United States $0.050B 0.00
Intensity Therapeutics (INTS) United States $0.050B 0.00
VistaGen Therapeutics (VTGN) United States $0.049B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.048B 0.00
Science 37 Holdings (SNCE) United States $0.048B 0.00
Longeveron (LGVN) United States $0.046B 0.00
VTv Therapeutics (VTVT) United States $0.046B 0.00
MiNK Therapeutics (INKT) United States $0.045B 0.00
Celularity (CELU) United States $0.044B 0.00
Precision BioSciences (DTIL) United States $0.044B 0.00
Galena Biopharma (SLS) United States $0.043B 0.00
Portage Biotech (PRTG) $0.043B 0.00
Quince Therapeutics (QNCX) United States $0.042B 0.00
Fortress Biotech (FBIO) United States $0.040B 0.00
Dare Bioscience (DARE) United States $0.040B 0.00
Cognition Therapeutics (CGTX) United States $0.040B 0.00
Connect Biopharma Holdings (CNTB) United States $0.040B 0.00
Coya Therapeutics (COYA) United States $0.040B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Bolt Biotherapeutics (BOLT) United States $0.039B 0.00
IN8bio (INAB) United States $0.039B 0.00
Mainz Biomed (MYNZ) Germany $0.038B 0.00
NextCure (NXTC) United States $0.038B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.037B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Miromatrix Medical (MIRO) United States $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.036B 0.00
UNITY Biotechnology (UBX) United States $0.036B 0.00
Telesis Bio (TBIO) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Checkpoint Therapeutics (CKPT) United States $0.034B 0.00
Aligos Therapeutics (ALGS) United States $0.033B 0.00
Candel Therapeutics (CADL) United States $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.033B 0.00
NuCana (NCNA) United Kingdom $0.032B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.032B 0.00
Rain Oncology (RAIN) United States $0.031B 0.00
BeyondSpring (BYSI) United States $0.031B 0.00
Axcella Health (AXLA) United States $0.031B 0.00
Neoleukin Therapeutics (NLTX) United States $0.030B 0.00
Cyclo Therapeutics (CYTH) United States $0.030B 0.00
Elevation Oncology (ELEV) United States $0.030B 0.00
Biora Therapeutics (BIOR) United States $0.030B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.028B 0.00
Forte Biosciences (FBRX) United States $0.028B 0.00
TradeUP Acquisition (UPTD) United States $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Liminal BioSciences (LMNL) Canada $0.026B 0.00
KALA BIO (KALA) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Pluri (PLUR) Israel $0.024B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.024B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Sensei Biotherapeutics (SNSE) United States $0.023B 0.00
GENPREX (GNPX) United States $0.023B 0.00
Elutia (ELUT) United States $0.023B 0.00
Synlogic (SYBX) United States $0.023B 0.00
Kineta (KA) United States $0.022B 0.00
Aptose Biosciences (APTO) Canada $0.022B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.022B 0.00
Alzamend Neuro (ALZN) United States $0.021B 0.00
YS Biopharma (YS) China $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
Medicenna Therapeutics (MDNA) Canada $0.021B 0.00
Seelos Therapeutics (SEEL) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Senti Biosciences (SNTI) United States $0.020B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Acorda Therapeutics (ACOR) United States $0.019B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.019B 0.00
Purple Biotech (PPBT) Israel $0.019B 0.00
Mustang Bio (MBIO) United States $0.019B 0.00
Catalyst Biosciences (CBIO) United States $0.019B 0.00
Virios Therapeutics (VIRI) United States $0.018B 0.00
Edesa Biotech (EDSA) Canada $0.018B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
AquaBounty Technologies (AQB) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.017B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.017B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Vascular Biogenics (VBLT) Israel $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
VBI Vaccines (VBIV) United States $0.015B 0.00
CalciMedica (CALC) United States $0.015B 0.00
ZIVO Bioscience (ZIVO) United States $0.015B 0.00
RenovoRx (RNXT) United States $0.014B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.014B 0.00
Frequency Therapeutics (FREQ) United States $0.014B 0.00
Senesco Technologies (ELOX) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.013B 0.00
Biofrontera (BFRI) United States $0.013B 0.00
Atreca (BCEL) United States $0.013B 0.00
AEterna Zentaris (AEZS) Canada $0.012B 0.00
Landos Biopharma (LABP) United States $0.012B 0.00
TFF Pharmaceuticals (TFFP) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
Organovo Holdings (ONVO) United States $0.012B 0.00
Pasithea Therapeutics (KTTA) United States $0.012B 0.00
Cingulate (CING) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Avalon GloboCare (ALBT) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.011B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
ARAVIVE, INC (ARAV) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Talis Biomedical (TLIS) United States $0.010B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.009B 0.00
Trevena (TRVN) United States $0.009B 0.00
Blue Water Biotech (BWV) United States $0.009B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Bionomics (BNOX) Australia $0.009B 0.00
Sunshine Biopharma (SBFM) Canada $0.009B 0.00
Cohbar (CWBR) United States $0.008B 0.00
Monopar Therapeutics (MNPR) United States $0.008B 0.00
Comera Life Sciences Holdings (CMRA) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Atrinsic (PTIX) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Kintara Therapeutics (KTRA) United States $0.008B 0.00
Lexaria Bioscience (LEXX) Canada $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.007B 0.00
Aileron Therapeutics (ALRN) United States $0.007B 0.00
Applied Molecular Transport (AMTI) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
TRACON Pharmaceuticals (TCON) United States $0.007B 0.00
Athersys (ATHX) United States $0.007B 0.00
Bright Minds Biosciences (DRUG) United States $0.007B 0.00
Exicure (XCUR) United States $0.006B 0.45
CervoMed (CRVO) United States $0.006B 0.00
Aytu BioPharma (AYTU) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Benitec Biopharma (BNTC) United States $0.005B 0.00
Bellerophon Therapeutics (BLPH) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Femasys (FEMY) United States $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Hillstream BioPharma (HILS) United States $0.004B 0.00
Aptevo Therapeutics (APVO) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Panbela Therapeutics (PBLA) United States $0.004B 0.00
ABVC BioPharma (ABVC) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Aceragen (ACGN) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
First Wave BioPharma (FWBI) United States $0.002B 0.07
Bone Biologics (BBLG) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 17.44
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00